The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions - Document - Gale OneFile: Health and Medicine
![SciELO - Brasil - Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of ... SciELO - Brasil - Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of ...](https://minio.scielo.br/documentstore/1678-4596/yp997Cm6C4BHtcws6hvVbnh/eac230c641da599672ea080be2768bb84bd930c2.jpg)
SciELO - Brasil - Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of ...
![Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/561936/561936_Thumb_400.jpg)
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology
![SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook](https://minio.scielo.br/documentstore/2175-9790/TjKWXnrBxMvtPZWgNMDFxMM/b6b81950a2e296abac549644d5c6848b44165ac2.jpg)
SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
![SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook](https://minio.scielo.br/documentstore/2175-9790/TjKWXnrBxMvtPZWgNMDFxMM/05530cfb309b03172203d0f52ba052ed9fd5e2e9.jpg)
SciELO - Brazil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
![Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology](https://www.frontiersin.org/files/Articles/561936/fonc-10-561936-HTML-r1/image_m/fonc-10-561936-t002.jpg)
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics | Oncology
![Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cb07bdccd7c7e764d8e619d6a15ecce23b7d8307/49-Table1.4-1.png)
Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar
![Table 2 from Natural Products as Alternative Choices for P-Glycoprotein (P- gp) Inhibition | Semantic Scholar Table 2 from Natural Products as Alternative Choices for P-Glycoprotein (P- gp) Inhibition | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aee9588a797ef8c0d21cd66a91c055219a25a7e0/10-Table2-1.png)
Table 2 from Natural Products as Alternative Choices for P-Glycoprotein (P- gp) Inhibition | Semantic Scholar
![P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study | SpringerLink P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40264-015-0299-3/MediaObjects/40264_2015_299_Fig1_HTML.gif)
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study | SpringerLink
![Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b533fdc9bb24a5477f10095337cfc2db4edee6ce/3-Table1-1.png)